1.World Health Organization, Global statusreport on alcohol and health 2014. Available from: URL:http://apps.who.int/iris/bitstream/10665/112736/1/9789240692763_eng.pdf?ua=1.
2.L. A. Streba, C. C. Vere, C. T. Strebaand M. E. Ciurea, Focus on alcoholic liver disease: From nosography totreatment,World J. Gastroenterol., 2014, 20(25), 8040–8047.
3.S. Fleming, S. Toratani, T.Shea-Donohue, Y. Kashiwabara,
S. N. Vogel and E. S. Metcalf, Pro- andAnti-Inflammatory
Gene Expression in the Murine SmallIntestine and Liver
after Chronic Exposure to Alcohol,Alcohol.: Clin. Exp. Res.,2001, 25(4), 579–589.
4.B. Lin, F. Zhang, Y. Yu, Q. Jiang, Z.Zhang, J. Wang and
Y. Li, Marine collagen peptides protectagainst early alcoholic liver injury in rats, Br. J. Nutr., 2012, 107(8),1160–1166.
5.G. Szabo, P. Mandrekar, J. Petrasek andD. Catalano, The
unfolding web of innate immunedysregulation in alcoholic
liver injury, Alcohol.: Clin. Exp. Res.,2011, 35(5), 782–786.
6.A. Rocco, D. Compare, D. Angrisani, M.Sanduzzi
Zamparelli and G. Nardone, Alcoholicdisease: Liver and
beyond, World J. Gastroenterol., 2014,20(40), 14652–14659.
7.P. D. Cani and N. M. Delzenne, Gutmicroflora as a target
for energy and metabolic homeostasis,Curr. Opin. Clin.
Nutr. Metab. Care., 2007, 10(6), 729–734.
8.S. R. Gill, M. Pop, R. T. Deboy, P. B.Eckburg,
P. J. Turnbaugh, B. S. Samuel, J. I.Gordon, D. A. Relman,
C. M. Fraser-Liggett and K. E. Nelson,Metagenomic analy
sis of the human distal gut microbiome,Science, 2006,
312(5778), 1355–1359.
9.P. J. Turnbaugh, R. E. Ley, M. Hamady,C. M. Fraser
Liggett, R. Knight and J. I. Gordon, Thehuman micro
biome project, Nature, 2007, 449(7164),804–810.
10.F. Casafont Morencos, G. de las HerasCastaño, L. Martín
Ramos, M. J. Arias, F. Ledesma and F. PonsRomero, Small
bowel bacterial overgrowth in patientswith alcoholic
cirrhosis, Dig. Dis. Sci., 1996, 41(3),552–556.
11.A. Keshavarzian, A. Farhadi, C. B.Forsyth, J. Rangan,
S. Jakate, M. Shaikh, A. Banan and J. Z.Fields, Evidence
that chronic alcohol exposure promotesintestinal oxidative stress,intestinal hyperpermeability and endotoxemia priorto development of alcoholic steatohepatitis in rats, J. Hepatol., 2009, 50(3),538–547.
12.H. J. Wang, B. Gao, S. Zakhari and L.E. Nagy, Inflam
mation in Alcoholic Liver Disease, Annu.Rev. Nutr., 2012,
32, 343–368.
13.A. W. Yan, D. E. Fouts, J. Brandl, P.Stärkel, M. Torralba, E. Schott, H. Tsukamoto, K. E. Nelson, D. A. Brenner andB. Schnabl, Enteric dysbiosis associated with a mouse model of alcoholic liverdisease, Hepatology, 2011, 53(1), 96–105.
14.P. Mandrekar and G. Szabo, Signallingpathways in alcoholinduced liver inflammation, J. Hepatol., 2009, 50(6),1258–1266.
15.A. Parlesak, C. Schäfer, T. Schütz, J.C. Bode and C. Bode, Increased intestinal permeability to macromolecules andendotoxemia in patients with chronic alcohol abuse in
difffferent stages of alcohol-inducedliver disease, J. Hepatol., 2000, 32(5), 742–747.
16.M. Fujimoto, M. Uemura, Y. Nakatani, S.Tsujita,
K. Hoppo, T. Tamagawa, H. Kitano, M.Kikukawa, T. Ann,
Y. Ishii, H. Kojima, S. Sakurai, R.Tanaka, T. Namisaki,
R. Noguchi, T. Higashino, E. Kikuchi, K.Nishimura,
A. Takaya and H. Fukui, Plasma endotoxinand serum cyto
kine levels in patients with alcoholichepatitis: relation to severity of Liver disturbance, Alcohol.: Clin. Exp.Res., 2000,24(4 Suppl), 48S–54S.
17.A. A. Nanji, K. Jokelainen, A.Rahemtulla, L. Miao, F. Fogt,H. Matsumoto, S. R. Tahan and G. L. Su, Activationof
nuclear factor kappa B and cytokineimbalance in experi
mental alcoholic liver disease in the rat,Hepatology, 1999, 30(4), 934–943.
18.M. G. Neuman, Y. Maor, R. M. Nanau, E.Melzer, H. Mell,
M. Opris, L. Cohen and S. Malnick,Alcoholic Liver Disease:
Role of Cytokines, Biomolecules, 2015,5(3), 2023–2034.
19 M. M. Jaurigue and M. S. Cappell,Therapy for alcoholic
liver disease, World J. Gastroenterol.,2014, 20(9), 2143–2158.
20.M. I. Torres, M. I. Fernández, A. Giland A. Ríos, Dietary nucleotides have cytoprotective properties in rat liverdamaged by thioacetamide, Life Sci., 1998, 62(1), 13–22.
21.S. Iijima, T. Tsujinaka, M. Kishibuchi,Y. Kido, C. Ebisui, K. Kan, M. Yano and T. Mori, A total parenteral nutrition
solution supplemented with a nucleosideand nucleotide
mixture sustains intestinal integrity, butdoes not stimulate intestinal function after massive bowel resection inrats,Nutr, 1996, 126(3), 589–595.
22 M. E. Evans, J. Tian, L. H. Gu, D. P.Jones and T. R. Ziegler, Dietary Supplementation With Orotate and UracilIncreases Adaptive Growth of Jejunal Mucosa After Massive Small Bowel Resectionin Rats, JPEN, J. Parenter. Enteral Nutr., 2005, 29(5), 315–321.
23.A. Gil, Modulation of the immuneresponse mediated by
dietary nucleotides, Eur. J. Clin. Nutr.,2002, 56(Suppl. 3),
S1–S4.
24.A. Singhal, G. Macfarlane, S.Macfarlane, J. Lanigan,
K. Kennedy, A. Elias-Jones, T. Stephenson,P. Dudek and
A. Lucas, Dietary nucleotides and fecalmicrobiota in
formula-fed infants: a randomizedcontrolled trial,
Am. J. Clin. Nutr., 2008, 87(6),1785–1792.
25.C. Quast, E. Pruesse, P. Yilmaz, J.Gerken, T. Schweer,
P. Yarza, J. Peplies and F. O. Glöckner,The SILVA ribosomal
RNA gene database project: improved dataprocessing and
web-based tools, Nucleic Acids Res., 2013,41(Database
issue), D590–D596.
26.Q. Wang, G. M. Garrity, J. M. Tiedjeand J. R. Cole, Naive
Bayesian classifier for rapid assignmentof rRNA sequences
into the new bacterial taxonomy, Appl.Environ. Microbiol.,
2007, 73(16), 5261–5267.
27.M. A. Ortega, M. C. Nunez, A. Gil andA. Sánchez-Pozo,
Dietary nucleotides accelerate intestinalrecovery after food
deprivation in old rats, J. Nutr., 1995,125(6), 1413–1418.
28.C. P. Dancey, E. A. Attree and K. F.Brown, Nucleotide supplementation: a randomised double-blind placebo controlledtrial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449],Nutr. J., 2006, 5, 16.
29.Y. Wang, I. Kirpich, Y. Liu, Z. Ma, S.Barve, C. J. McClain and W. Feng, Lactobacillus rhamnosus GG treatment
potentiates intestinal hypoxia-induciblefactor, promotes
intestinal integrity and amelioratesalcohol-induced liver injury, Am. J. Pathol., 2011, 179(6), 2866–2875.
30.B. Koletzko, S. Baker, G. Cleghorn, U.F. Neto, S. Gopalan,O. Hernell, Q. S. Hock, P. Jirapinyo, B. Lonnerdal,
P. Pencharz, H. Pzyrembel, J.Ramirez-Mayans, R. Shamir,
D. Turck, Y. Yamashiro and D. Zong-Yi,Global standard
for the composition of infant formula:recommendations
of an ESPGHAN coordinated internationalexpert group,
J. Pediatr. Gastroenterol. Nutr., 2005,41(5), 584–599.
31.M. Xu, Y. Ma, L. Xu, Y. Xu and Y. Li,Developmental effffects of dietary nucleotides in second-generation weanedrats, J. Med. Food, 2013, 16(12), 1146–1152.
32.B. Gao and R. Bataller, Alcoholic liverdisease: pathogenesis and new therapeutic targets, Gastroenterology, 2011,141(5), 1572–1585.
33.J. Liu, Ethanol and liver: recentinsights into the mechanisms of ethanol-induced fatty liver, World J.Gastroenterol., 2014, 20(40), 14672–14685.
34.N. Horiguchi, L. Wang, P. Mukhopadhyay,O. Park, W. I. Jeong, F. Lafdil, D. Osei-Hyiaman, A. Moh, X. Y. Fu,
P. Pacher, G. Kunos and B. Gao, Cell type-dependentpro
and anti-inflammatory role of signaltransducer and activator of transcription 3 in alcoholic liver injury,Gastroenterology, 2008, 134(4), 1148–1158.
35.F. Hong, W. H. Kim, Z. Tian, B. Jaruga,E. Ishac, X. Shen
and B. Gao, Elevated interleukin-6 duringethanol con
sumption acts as a potential endogenousprotective cyto
kine against ethanol-induced apoptosis inthe liver:
involvement of induction of Bcl-2 andBcl-x(L) proteins,
Oncogene, 2002, 21(1), 32–43.
36.L. Bavia, Í. A. de Castro and L. Isaac,C57BL/6 and A/J Mice Have Difffferent Inflammatory Response and Liver LipidProfile in Experimental Alcoholic Liver Disease, Mediators Inflammation, 2015,2015, 491641.
37.F. M. Chang, S. M. Reyna, J. C.Granados, S. J. Wei,
W. Innis-Whitehouse, S. K. Maffiffiffi, E.Rodriguez, T. J. Slaga and J. D. Short, Inhibition of neddylation represseslipopolysaccharide-induced proinflammatory cytokine production in macrophagecells, J. Biol. Chem., 2012, 287(42), 35756– 35767.
38.V. Purohit, J. C. Bode, C. Bode, D. A.Brenner,
M. A. Choudhry, F. Hamilton, Y. J. Kang,A. Keshavarzian,
R. Rao, R. B. Sartor, C. Swanson and J. R.Turner, Alcohol,
intestinal bacterial growth, intestinalpermeability to
endotoxin, and medical consequences:summary of a
symposium, Alcohol, 2008, 42(5), 349–361.
39.D. Compare, P. Coccoli, A. Rocco and O.M. Nardone,
Maria .S. De, M. Cartenì, G. Nardone,Gut–liver axis: the
impact of gut microbiota on non alcoholicfatty liver
disease, Nutr., Metab. Cardiovasc. Dis,2012, 22(6), 471–476.
40.I. A. Kirpich, N. V. Solovieva, S. N.Leikhter, N. A. Shidakova, O.V.Lebedeva,P. I. Sidorov, T. A. Bazhukova, A. G.Soloviev,S. S. Barve, C. J. McClain and M. Cave, Probiotics restore bowel floraand improve liver enzymes in human alcoholinduced liver injury: a pilot study,Alcohol, 2008, 42(8), 675–682.
41.S. Leclercq, S. Matamoros, P. D. Cani,A. M. Neyrinck,
F. Jamar, P. Stärkel, K. Windey, V.Tremaroli, F. Bäckhed,
K. Verbeke, P. de Timary and N. M.Delzenne, Intestinal
permeability, gut-bacterial dysbiosis, andbehavioral
markers of alcohol-dependence severity,Proc. Natl. Acad.
Sci. U. S. A., 2014, 111(42), E4485–E4493.
42.A. W. Yan, D. E. Fouts, J. Brandl, P.Stärkel, M. Torralba,E. Schott, H. Tsukamoto, K. E. Nelson, D. A. Brenner andB. Schnabl, Enteric dysbiosis associated with a mouse model of alcoholic liverdisease, Hepatology, 2011, 53(1),96–105.
43.S. Ceccarelli, V. Nobili and A. Alisi,Toll-like receptor mediated signaling cascade as a regulator of the inflammationnetwork during alcoholic liver disease, World J. Gastroenterol., 2014, 20(44),16443–16451.
44.C. Schäfer, A. Parlesak, C. Schütt, J.C. Bode and C. Bode,Concentrations of lipopolysaccharide- bindingprotein,bactericidal/permeability-increasing protein, soluble CD14 and plasmalipids in relation to endotoxaemia in patients with alcoholic liver disease,Alcohol, 2002, 37(1), 81–86.
45.I. Hritz, P. Mandrekar, A. Velayudham,D. Catalano,
A. Dolganiuc, K. Kodys, E. Kurt-Jones andG. Szabo, The
critical role of toll-like receptor (TLR)4 in alcoholic liver disease is independent of the common TLR adapter
MyD88, Hepatology, 2008, 48(4), 1224–1231.
46.C. A. Bradham, J. Plümpe, M. P. Manns,D. A. Brenner and
C.Trautwein, Mechanisms of hepatictoxicity. I. TNF
induced liver injury, Am. J. Physiol.,1998, 275(3 Pt 1),
G387–G392.
47.C. J. Lin, C. C. Chiu, Y. C. Chen, M.L. Chen, T. C. Hsu and B. S. Tzang, Taurine Attenuates Hepatic Inflammation
in Chronic Alcohol-Fed Rats ThroughInhibition of
TLR4/MyD88 Signaling, J. Med. Food, 2015,18(12), 1291–
1298.
48.J. Khoury, J. C. Ibla, A. S. Neish andS. P. Colgan, Antiinflammatory adaptation to hypoxia through adenosinemediatedcullin-1 deneddylation, J. Clin. Invest., 2007, 117(3), 703–711. Paper Food& Function
2908 | Food Funct., 2016, 7, 2898–2908 This journal is © The Royal Society of Chemistry 2016 ViewArticle Online
Published on 24 May 2016. Downloaded byFLORIDA ATLANTIC UNIVERSITY